FDA approves anti-obesity drug as first sleep apnea medication - Washington Examiner
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have obesity
https://www.washingtonexaminer.com/policy/healthcare/3268060/fda-approves-anti-obesity-drug-as-first-sleep-apnea-medication/